From Adhesion to Detachment: Strategies to Design Tissue-Adhesive Hydrogels

IF 4 Q2 ENGINEERING, BIOMEDICAL
Minh Hieu Ho, Quinn van Hilst, Xiaolin Cui, Yogambha Ramaswamy, Tim Woodfield, Jelena Rnjak-Kovacina, Steven G. Wise, Khoon S. Lim
{"title":"From Adhesion to Detachment: Strategies to Design Tissue-Adhesive Hydrogels","authors":"Minh Hieu Ho,&nbsp;Quinn van Hilst,&nbsp;Xiaolin Cui,&nbsp;Yogambha Ramaswamy,&nbsp;Tim Woodfield,&nbsp;Jelena Rnjak-Kovacina,&nbsp;Steven G. Wise,&nbsp;Khoon S. Lim","doi":"10.1002/anbr.202300090","DOIUrl":null,"url":null,"abstract":"<p>The use of tissue adhesives dates to 1940s when surgical glues were introduced for wound closure applications. However, current clinically used tissue adhesives (fibrin and cyanoacrylate glues) have limited adhesion strength and biocompatibility issues which restrict their performance in targeted applications. Due to this unmet clinical challenge, there is a need to develop next-generation tissue adhesives to expand the current limited available options. Another factor that is often overlooked in the field is the consequence of when these tissue adhesives fail while in use in specific applications. In this review, the complications arising from tissue adhesives that have insufficient adhesion strength are covered, where unintentional loosening and detachment can lead to serious complications depending on both the applications and scenarios in which the adhesives are used. Next, the current methodologies employed to design tissue-adhesive hydrogels targeting specific applications are also collated. Finally, the different strategies to engineer on-demand removal property of these tissue-adhesive hydrogels are consolidated, including some perspectives on current challenges and outlooks in this field.</p>","PeriodicalId":29975,"journal":{"name":"Advanced Nanobiomed Research","volume":"4 2","pages":""},"PeriodicalIF":4.0000,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/anbr.202300090","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced Nanobiomed Research","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/anbr.202300090","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

The use of tissue adhesives dates to 1940s when surgical glues were introduced for wound closure applications. However, current clinically used tissue adhesives (fibrin and cyanoacrylate glues) have limited adhesion strength and biocompatibility issues which restrict their performance in targeted applications. Due to this unmet clinical challenge, there is a need to develop next-generation tissue adhesives to expand the current limited available options. Another factor that is often overlooked in the field is the consequence of when these tissue adhesives fail while in use in specific applications. In this review, the complications arising from tissue adhesives that have insufficient adhesion strength are covered, where unintentional loosening and detachment can lead to serious complications depending on both the applications and scenarios in which the adhesives are used. Next, the current methodologies employed to design tissue-adhesive hydrogels targeting specific applications are also collated. Finally, the different strategies to engineer on-demand removal property of these tissue-adhesive hydrogels are consolidated, including some perspectives on current challenges and outlooks in this field.

Abstract Image

从粘附到剥离:设计组织粘性水凝胶的策略
组织粘合剂的使用可追溯到 20 世纪 40 年代,当时手术用胶水被引入伤口闭合应用。然而,目前临床上使用的组织粘合剂(纤维蛋白胶和氰基丙烯酸酯胶)的粘合强度和生物相容性有限,限制了其在目标应用中的性能。鉴于这一尚未解决的临床难题,有必要开发新一代组织粘合剂,以扩大目前有限的可用选择范围。该领域经常忽视的另一个因素是这些组织粘合剂在特定应用中失效后的后果。在本综述中,我们将讨论粘附强度不足的组织粘合剂所引起的并发症,根据粘合剂的应用和使用场景,意外松动和脱落可能会导致严重的并发症。接下来,还整理了目前针对特定应用设计组织粘合水凝胶的方法。最后,总结了设计这些组织粘合水凝胶按需移除特性的不同策略,包括对该领域当前挑战和前景的一些看法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Advanced Nanobiomed Research
Advanced Nanobiomed Research nanomedicine, bioengineering and biomaterials-
CiteScore
5.00
自引率
5.90%
发文量
87
审稿时长
21 weeks
期刊介绍: Advanced NanoBiomed Research will provide an Open Access home for cutting-edge nanomedicine, bioengineering and biomaterials research aimed at improving human health. The journal will capture a broad spectrum of research from increasingly multi- and interdisciplinary fields of the traditional areas of biomedicine, bioengineering and health-related materials science as well as precision and personalized medicine, drug delivery, and artificial intelligence-driven health science. The scope of Advanced NanoBiomed Research will cover the following key subject areas: ▪ Nanomedicine and nanotechnology, with applications in drug and gene delivery, diagnostics, theranostics, photothermal and photodynamic therapy and multimodal imaging. ▪ Biomaterials, including hydrogels, 2D materials, biopolymers, composites, biodegradable materials, biohybrids and biomimetics (such as artificial cells, exosomes and extracellular vesicles), as well as all organic and inorganic materials for biomedical applications. ▪ Biointerfaces, such as anti-microbial surfaces and coatings, as well as interfaces for cellular engineering, immunoengineering and 3D cell culture. ▪ Biofabrication including (bio)inks and technologies, towards generation of functional tissues and organs. ▪ Tissue engineering and regenerative medicine, including scaffolds and scaffold-free approaches, for bone, ligament, muscle, skin, neural, cardiac tissue engineering and tissue vascularization. ▪ Devices for healthcare applications, disease modelling and treatment, such as diagnostics, lab-on-a-chip, organs-on-a-chip, bioMEMS, bioelectronics, wearables, actuators, soft robotics, and intelligent drug delivery systems. with a strong focus on applications of these fields, from bench-to-bedside, for treatment of all diseases and disorders, such as infectious, autoimmune, cardiovascular and metabolic diseases, neurological disorders and cancer; including pharmacology and toxicology studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信